Treatment

Rezpegaldesleukin clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
This study is looking into a new medicine called Rezpegaldesleukin for people recently diagnosed with Type 1 Diabetes. It aims to see if the medicine can help their bodies make more insulin. Participants will receive the medicine or a dummy treatment over six months.
For: Type 1 Diabetes Mellitus
United States · Canada